Antibodies Archives

News and Trends 25 Sep 2017

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

Sanofi, in collaboration with the US National Institute of Health, is developing an antibody HIV treatment that can kill 99% of strains. Human immunodeficiency virus (HIV) is notoriously difficult to treat as it mutates so quickly. Some patients develop ‘broadly neutralizing antibodies’ that attack fundamental parts of the virus, and are therefore very powerful tools. Researchers […]

September 25, 2017 - 3 minutesmins - By Alex Dale

Morphosys Janssen Guselkumab approval psoriasis

News and Trends 18 Sep 2017

Update: After 25 years, MorphoSys Gets its First Antibody Approved

Update (19/09/2017): Janssen has received a positive CHMP opinion recommending the approval of Tremfya (guselkumab) in Europe for moderate to severe plaque psoriasis. The approval could make Tremfya the first antibody developed by MorphoSys to hit the European market, just a few months after its US approval. Originally published on 14/07/2017 Janssen has received FDA approval for Tremfya […]

September 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

David Chiswell interview Kymab Antibodies

Interview 18 Sep 2017

David Chiswell: “We are getting close to the best way of making antibodies”

We interviewed David Chiswell, a pioneer in the development of therapeutic antibodies and now the CEO of Kymab, which he has the ambition to turn into the “European Genentech.” David Chiswell was, along with Greg Winter, one of the co-founders of Cambridge Antibody Technology. “We both wanted to start an antibody company,” says Chiswell. “And […]

September 18, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Sep 2017

A Swedish-Spanish Team Takes on a New Immuno-Oncology Target

Alligator Bioscience will collaborate with the University of Navarra, Spain, to study the potential of CD137 as a target for new cancer immunotherapies. Alligator Bioscience, based in Lund, Sweden, has teamed up with Prof. Ignacio Melero at the Center for Applied Medical Research (CIMA) at the University of Navarra to study the biological effects of activating […]

September 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 11 Sep 2017

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

Jan van de Winkel co-founded Genmab as CSO and then became CEO to develop the antibody company into a fully independent commercial enterprise. Here’s his strategy. Since its foundation in 1999, Genmab has become Europe’s largest biotech and a proud parent of a half billion-euro drug, daratumumab. Co-founding CSO Jan van de Winkel played a […]

September 11, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 8 Sep 2017

Checkpoint Inhibitor from Regeneron and Sanofi gets Priority After Breakup

The FDA has granted breakthrough therapy designation to Regeneron and Sanofi for cemiplimab, just a month after announcing they will part ways soon. Cemiplimab (REGN2810) has been granted breakthrough therapy designation by the FDA for the treatment of metastatic cutaneous squamous cell carcinoma (CSCC), considered the second deadliest skin cancer after melanoma. The antibody is a […]

September 8, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 6 Sep 2017

Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment

Tiziana makes moves towards a €37B market with an oral monoclonal antibody (mAb) formulation to treat non-alcoholic steatohepatitis (NASH) . Tiziana, which has previously developed compounds targeting the second most deadly form of cancer, has produced a novel formulation of the anti-CD3 mAb, Foralumab. The biologic will be tested in patients with NASH and other […]

September 6, 2017 - 3 minutesmins - By Alex Dale

News and Trends 5 Sep 2017

FREE TICKET Giveaway – European Antibody Congress

Our wonderful readers now have the chance to win a FREE ticket for the European Antibody Congress in Basel, Switzerland! On 31st October – 2nd November you will have the opportunity to participate in a vibrant gathering with more than 200 speakers and 650 influential decision makers from across academia and the biotech and pharmaceutical industry! Apply today and […]

September 5, 2017 - 2 minutesmins - By External Contributor

novimmune shire hemophilia antibody roche

News and Trends 18 Jul 2017

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment of hemophilia A. Novimmune is a biotech from Geneva that specializes in developing antibodies. Back in 2015, it struck a research collaboration with Baxalta, which has since been acquired Shire. The Irish pharma has now decided to […]

July 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 20 Jun 2017

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

argenx’s 2015 deal with Leo Pharma for anti-inflammatory antibodies continues to pay off, though it hasn’t been disclosed by how much exactly. Two years ago, Ghent-based argenx and Danish Leo Pharma teamed up to develop antibodies to counter inflammatory diseases in a deal totalling €105M. argenx just received its second preclinical milestone for granting Leo access to […]

June 20, 2017 - 1 minutemin - By Evelyn Warner

News and Trends 12 Jun 2017

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced companies in the mRNA therapeutics field, has reported preclinical data for a new class of mRNA drugs that instruct the body to create its own […]

June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Jun 2017

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal that could earn the diabetes specialist up to €370M in milestones. The immuno-oncology biotech Innate Pharma has in-licensed a new clinical-stage antibody candidate from Novo Nordisk to reinforce its position in the crowded space. In exchange for its anti-C5aR antibody, IPH5401, […]

June 6, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Antibodies

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

Update: After 25 years, MorphoSys Gets its First Antibody Approved

David Chiswell: “We are getting close to the best way of making antibodies”

A Swedish-Spanish Team Takes on a New Immuno-Oncology Target

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

Checkpoint Inhibitor from Regeneron and Sanofi gets Priority After Breakup

Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment

FREE TICKET Giveaway – European Antibody Congress

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!